UNICK FIX-A-FORM AND PRINTERS | ZENITH DRUGS LTD. | UNICK FIX-A-FORM AND PRINTERS/ ZENITH DRUGS LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 28.5 | - | - | View Chart |
P/BV | x | 1.2 | 6.3 | 18.5% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS ZENITH DRUGS LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
ZENITH DRUGS LTD. Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ ZENITH DRUGS LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | NA | - | |
Low | Rs | 32 | NA | - | |
Sales per share (Unadj.) | Rs | 120.5 | 2,863.0 | 4.2% | |
Earnings per share (Unadj.) | Rs | 4.1 | 128.8 | 3.2% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 161.4 | 7.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 431.1 | 12.5% | |
Shares outstanding (eoy) | m | 5.49 | 0.40 | 1,372.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0 | - | |
Avg P/E ratio | x | 11.1 | 0 | - | |
P/CF ratio (eoy) | x | 4.0 | 0 | - | |
Price / Book Value ratio | x | 0.8 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 39 | 232.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 1,145 | 57.8% | |
Other income | Rs m | 5 | 12 | 43.4% | |
Total revenues | Rs m | 667 | 1,157 | 57.6% | |
Gross profit | Rs m | 88 | 100 | 87.9% | |
Depreciation | Rs m | 39 | 13 | 300.6% | |
Interest | Rs m | 24 | 26 | 90.0% | |
Profit before tax | Rs m | 30 | 72 | 41.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 21 | 36.3% | |
Profit after tax | Rs m | 22 | 52 | 43.5% | |
Gross profit margin | % | 13.3 | 8.7 | 152.2% | |
Effective tax rate | % | 25.0 | 28.5 | 87.6% | |
Net profit margin | % | 3.4 | 4.5 | 75.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 839 | 35.9% | |
Current liabilities | Rs m | 287 | 718 | 40.0% | |
Net working cap to sales | % | 2.1 | 10.6 | 20.1% | |
Current ratio | x | 1.0 | 1.2 | 89.8% | |
Inventory Days | Days | 4 | 7 | 53.0% | |
Debtors Days | Days | 72,349,839 | 1,572 | 4,603,369.1% | |
Net fixed assets | Rs m | 402 | 140 | 286.6% | |
Share capital | Rs m | 55 | 4 | 1,371.3% | |
"Free" reserves | Rs m | 241 | 168 | 143.1% | |
Net worth | Rs m | 296 | 172 | 171.6% | |
Long term debt | Rs m | 89 | 84 | 106.2% | |
Total assets | Rs m | 705 | 979 | 72.0% | |
Interest coverage | x | 2.3 | 3.7 | 60.5% | |
Debt to equity ratio | x | 0.3 | 0.5 | 61.9% | |
Sales to assets ratio | x | 0.9 | 1.2 | 80.2% | |
Return on assets | % | 6.6 | 8.0 | 82.3% | |
Return on equity | % | 7.6 | 29.9 | 25.3% | |
Return on capital | % | 14.0 | 38.5 | 36.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | -44 | -99.1% | |
From Investments | Rs m | -27 | 1 | -2,549.1% | |
From Financial Activity | Rs m | -16 | 49 | -33.2% | |
Net Cashflow | Rs m | 0 | 6 | 5.8% |
Indian Promoters | % | 71.6 | 70.0 | 102.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 7.7 | 5.8% | |
FIIs | % | 0.0 | 5.8 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 30.0 | 94.7% | |
Shareholders | 1,622 | 1,117 | 145.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | ZENITH DRUGS LTD. | S&P BSE TECK |
---|---|---|---|
1-Day | 5.00% | 6.16% | 0.33% |
1-Month | 10.98% | 4.68% | -1.62% |
1-Year | 47.12% | -33.40% | 24.14% |
3-Year CAGR | 27.18% | -12.67% | 10.09% |
5-Year CAGR | 23.35% | -7.81% | 15.93% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the ZENITH DRUGS LTD. share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of ZENITH DRUGS LTD. the stake stands at 70.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of ZENITH DRUGS LTD..
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
ZENITH DRUGS LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of ZENITH DRUGS LTD..
For a sector overview, read our media sector report.
After opening the day marginally higher, Indian share markets reversed the trend as the session progressed and ended the day lower.